Carbidopa (monohydrate)


CAS No. : 38821-49-7

(Synonyms: (S)-(-)-Carbidopa (monohydrate))

38821-49-7
Price and Availability of CAS No. : 38821-49-7
Size Price Stock
100mg $25 In-stock
250mg $43 In-stock
500mg $62 In-stock
1g $88 In-stock
5 g Get quote
10 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B0311A
M.Wt: 244.24
Formula: C10H16N2O5
Purity: >98 %
Solubility: DMSO : 20 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 38821-49-7 :

Carbidopa ((S)-(-)-Carbidopa) monohydrate, a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa monohydrate is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa monohydrate inhibits pancreatic cancer cell and tumor growth[1][2]. In Vitro: Carbidopa ((S)-(-)-Carbidopa) monohydrate exhibits activities similar to that described for other AhR ligands in BχPC3 and Capan-2 cells, namely the induction of CYP1A1 and CYP1A2, which are inhibited by AhR antagonists such as CH223191[1].
Carbidopa, a aromatic-L-amino acid decarboxylase inhibitor, is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Carbidopa is lethal (IC50=29 μM)[3]. In Vivo: Carbidopa monohydrate also induces nuclear uptake of the AhR, and in vivo studies show that carbidopa at a dose of 1 mg/mouse significantly inhibits tumor growth in athymic nude mice bearing BχPC3 cells as xenografts[1].

Your information is safe with us.